Hormonal
Peripheral GLP-1 receptor agonists (GLP-1RAs) exert brain-mediated anorectic effects primarily via access to circumventricular organs (CVOs) like the area postrema and median eminence, rather than crossing the blood-brain barrier (BBB) or blood-cerebrospinal fluid barrier (BCB).
GLP-1 medications like Semaglutide and Liraglutide reduce appetite by signaling from the gut to specific brain regions (CVOs) via the vagus nerve, rather than crossing into the brain tissue itself. This explains why they are effective for weight loss even though very little drug actually enters the cerebrospinal fluid.
Peripherally administrated GLP-1RAs may access the brain via ME and AP, as well as other selective CVOs. We hence intend to suggest that gut-produced native GLP-1 and peripherally administrated GLP-1RA as therapeutic agent do not access the brain via BCB.
Why this rating
The paper is a review synthesizing multiple studies, including clinical data showing minimal CSF transfer despite significant weight loss.
Source
Current understanding and controversy on brain access of GLP-1 and GLP-1 receptor agonists
Jiao Feng et al. · Journal of Translational Internal Medicine · 2025
DOI 10.1515/jtim-2025-0026
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →